Form 4: Nuvalent CDO Exercises Options, Sells Shares Under 10b5-1 Plan

Nuvalent's Chief Development Officer, Darlene Noci, exercised stock options and subsequently sold an equivalent number of shares under a pre-arranged 10b5-1 trading plan.

Summary

• Darlene Noci, Chief Development Officer of Nuvalent, Inc., engaged in pre-planned transactions on August 25, 2025.
• Noci exercised stock options to acquire 4,000 shares of Class A Common Stock at an exercise price of $27.85 per share.
• Concurrently, Noci sold a total of 4,000 shares of Class A Common Stock in multiple transactions.
• The sales occurred at weighted average prices of $73.96 (1,348 shares), $74.93 (2,543 shares), and $75.63 (109 shares).
• All transactions were executed under a Rule 10b5-1 trading plan adopted on November 18, 2024.
• Following these transactions, Noci directly beneficially owns 48,034 shares of Class A Common Stock and 130,329 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The transactions represent a routine, pre-planned exercise of options and sale of shares by a key executive, resulting in a substantial personal profit. The pre-planned nature under Rule 10b5-1 mitigates any negative interpretation of insider selling, suggesting a planned liquidity event rather than a reaction to new company developments.

Positives

• The Chief Development Officer realized a significant profit from exercising stock options at $27.85 and selling shares at weighted average prices ranging from $73.96 to $75.63.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public information.

Negatives

• While pre-planned, the sale of shares by an insider could be perceived by some as a lack of confidence, though this is mitigated by the exercise-and-sell nature for liquidity and tax purposes.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view the insider's profit positively as it indicates value creation, but the sale of shares, even if pre-planned, might lead to minor speculation.

Key Dates

Recommendation

The filing details a routine, pre-planned insider transaction (exercise of options and subsequent sale of shares) under a Rule 10b5-1 plan. This type of transaction typically does not provide new fundamental information about the company's performance or future prospects that would warrant a change in investment recommendation. The net change in direct beneficial ownership from these specific transactions is zero, indicating a liquidity event rather than a significant change in the insider's conviction.

Keywords

Nuvalent, NUVL, insider trading, Form 4, stock options, 10b5-1 plan, Darlene Noci, Chief Development Officer